Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease

C Agostini1, R Zambello, R Sancetta

  • 1Padua University School of Medicine, Department of Clinical and Experimental Medicine, Padua, Italy.

Insights

Tumor necrosis factor (TNF) receptors and ligands are expressed on lung T cells in interstitial lung disease (ILD). This suggests their role in pulmonary immune regulation and alveolitis development in ILD patients.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Cell Biology

Background:

  • A novel superfamily of receptors interacting with tumor necrosis factor (TNF)-homologous ligands has been identified.
  • The role of these TNF-receptor and TNF-ligand superfamilies in the pulmonary environment remains largely unexplored.

Purpose of the Study:

  • To investigate the expression of key TNF-receptor and TNF-ligand members on bronchoalveolar lavage (BAL) T cells.
  • To evaluate the differential expression patterns in healthy subjects versus patients with interstitial lung disease (ILD).

Main Methods:

  • Analysis of T cells from BAL of healthy controls and patients with ILD (sarcoidosis, HIV infection, hypersensitivity pneumonitis).
  • Flow cytometry was used to assess the surface expression of specific TNF-receptors (CD27, CD30, CD40, CD95/Fas, CD120a, CD120b) and TNF-ligands (CD40L, CD70, CD30L, mTNFalpha).

Main Results:

  • Healthy controls showed minimal expression of most receptors/ligands, with CD27 on CD4+ cells and weak CD95/CD70 expression.
  • ILD patients exhibited distinct patterns: sarcoidosis patients had upregulated CD95 and CD70 on CD4+ T cells.
  • HIV and hypersensitivity pneumonitis patients showed CD8 alveolitis with high CD120b and CD70 expression.

Conclusions:

  • Discrete surface expression of TNF-receptors and ligands on alveolar T cells suggests their involvement in immune regulation.
  • These molecules likely contribute to the alveolitis observed in the pulmonary microenvironment of ILD.